{"disease":{"id":"rotavirus-vaccines","name":"rotavirus vaccines"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01733862","title":"Study to Assess the Impact of Vaccination on Hospitalizations and Outpatient Visits Due to Rotavirus Gastroenteritis","phase":"","overall_status":"COMPLETED","enrollment_count":5394,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT02914184","title":"Evaluation of Immunogenicity and Safety of Two Formulations of GSK Biologicals' Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1612,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT06882070","title":"ROTA-biotic: Measuring the Impact of Rotavirus Vaccines on Paediatric Antibiotic Usage","phase":"","overall_status":"COMPLETED","enrollment_count":1600,"lead_sponsor_name":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","has_results":false},{"nct_id":"NCT00353366","title":"To Evaluate Safety & Reactogenicity of GSK Bio's Human Rotavirus (HRV) Vaccine in Filipino Infants at Least 6 Weeks of Age at First Vaccination","phase":"","overall_status":"COMPLETED","enrollment_count":1439,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT03207750","title":"This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1280,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00480324","title":"Efficacy, Safety, Reactogenicity & Immunogenicity of the Rotarix Vaccine in Japanese Infants","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":765,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00969228","title":"Study to Evaluate Immunogenicity, Reactogenicity and Safety of Rotarix™ Vaccine in Korean Infants","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":684,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT01177826","title":"Effectiveness Study of GSK Biologicals' Rotarix TM Vaccine in Hospitalized Children","phase":"","overall_status":"COMPLETED","enrollment_count":643,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT00432380","title":"A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals' HRV Liquid Vaccine in Healthy Infants.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":375,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT03804489","title":"Using \"Decision Aids\" to Help the Infant Family to Decide the Use of Oral Rotavirus Vaccine","phase":"NA","overall_status":"UNKNOWN","enrollment_count":180,"lead_sponsor_name":"Taipei Medical University Shuang Ho Hospital","has_results":false},{"nct_id":"NCT05037435","title":"Safety and Immunological Efficacy of the Pentavalent Rotavirus Vaccine - Rota-V-Aid™ (Live Attenuated Oral, Freeze-dried) at Healthy Adults Aged 18 to 45 Years.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Limited Liability Company Pharm Aid","has_results":false}],"total":11},"guidelines":[],"source":"Drug Landscape verified database"}